✦ LIBER ✦

Clinical response and symptomatic remission in short- and long-term trials of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder

✍ Scribed by Greg W Mattingly, Richard H Weisler, Joel Young, Ben Adeyi, Bryan Dirks…

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P.1.i.038 Long-term safety and efficacy

✍ R. Lasser; R. Weisler; J. Young; G. Mattingly; J. Gao; L. Adler; L. Squires 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 108 KB

A Long-Term Open-Label Safety and Effect

✍ Findling, Robert L.; Cutler, Andrew J.; Saylor, Keith; Gasior, Maria; Hamdani, M 📂 Article 📅 2013 🏛 Mary Ann Liebert 🌐 English ⚖ 337 KB

Efficacy and Safety of Lisdexamfetamine

✍ Findling, Robert L.; Childress, Ann C.; Cutler, Andrew J.; Gasior, Maria; Hamdan 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 892 KB

EPA-0672 – Efficacy outcomes in age and

✍ Adler, L.A.; Dirks, B.; Adeyi, B.; Squires, L.A. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 French ⚖ 62 KB

Efficacy and Safety of Lisdexamfetamine

✍ Rakesh Jain, Thomas Babcock, Teodor Burtea, Bryan Dirks, Ben Adeyi… 📂 Article 📅 2013 🏛 Springer Healthcare Communications 🌐 English ⚖ 586 KB

P.7.a.009 Long-term effectiveness and sa

✍ J. McGough; A. Childress; S. Krishnan; R. Findling 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 60 KB